Paper Details

  1. Home
  2. Paper Details

[Rizatriptan: experience after 15 years of clinical use].

Author: Alvarez-EscuderoRocío, PascualJulio, Ramón-CarbajoCésar

English AbstractA summary of a research paper/publication written in English for a wider audience.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

Rizatriptan is a 5-HT1B/1D agonist used to treat migraine headaches. It has a fast onset of action and is highly effective within two hours. It is well-tolerated and has a safety profile similar to other triptans. Studies have shown that rizatriptan is cost-effective and preferred by patients. It is most effective when used early in a migraine attack and has also been shown to be effective in adolescents. Overall, rizatriptan is a first-line treatment for migraine headaches.
Paper Details　
Original Abstract of the Article :
We review the development of rizatriptan, one of the seven 5-HT1B/1D agonists available for the symptomatic treatment of migraine, emphasizing the most relevant contributions carried out from our country. Rizatriptan has shown the quickest onset of action, both in controlled studies and in the diffe...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/24288104

データ提供：米国国立医学図書館（NLM）

Rizatriptan: A 15-Year Journey in Migraine Treatment

Migraine is a debilitating neurological disorder that affects millions worldwide. This study reviews the development and clinical use of rizatriptan, a medication used for the symptomatic treatment of migraine. The study highlights the drug's rapid onset of action, high efficacy, and favorable tolerability profile, emphasizing its key contributions to migraine management.

Rizatriptan: A Fast and Effective Solution for Migraine Relief

Rizatriptan has consistently demonstrated a quick onset of action, providing rapid relief for migraine sufferers. This rapid relief translates into high efficacy levels within two hours of administration. Furthermore, its tolerability and safety profile are comparable to other triptans, making it a viable option for many patients. The efficacy of rizatriptan is like finding a cool breeze in the heat of a migraine attack, offering a quick and welcome respite.

Navigating Migraine Treatment: A Guide for Better Health

The study highlights the importance of early intervention for migraine attacks, emphasizing the benefits of taking rizatriptan at the first sign of a migraine. The drug's efficacy, tolerability, and rapid onset of action make it a valuable tool for migraine management. However, as with any medication, it's important to consult with a healthcare professional to determine the appropriate treatment approach for your specific needs. Like a wise camel navigating the desert, it's important to choose the right path for effective migraine management.

Dr.Camel's Conclusion

Rizatriptan has proven itself to be a reliable and effective treatment option for migraine attacks. Its rapid onset of action, high efficacy, and favorable safety profile make it a valuable tool for managing migraine headaches. This drug offers a ray of hope in the desert of migraine pain, providing relief and improving the quality of life for many individuals.
Date :
  1. Date Completed 2014-07-21
  2. Date Revised 2013-11-29
Further Info :

Pubmed ID

24288104

DOI: Digital Object Identifier

rn2013218

Related Literature

Article Analysis
・Effects of rizatriptan
SNS
PICO Info
in preparation
Languages

Spanish

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.